SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-262955
Filing Date
2022-10-14
Accepted
2022-10-14 16:16:15
Documents
12
Period of Report
2022-10-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d378058d8k.htm   iXBRL 8-K 30146
  Complete submission text file 0001193125-22-262955.txt   154517

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atai-20221013.xsd EX-101.SCH 2838
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE atai-20221013_lab.xml EX-101.LAB 18672
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atai-20221013_pre.xml EX-101.PRE 11672
6 EXTRACTED XBRL INSTANCE DOCUMENT d378058d8k_htm.xml XML 3521
Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 (617) 699-5876
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40493 | Film No.: 221311534
SIC: 2834 Pharmaceutical Preparations